Literature DB >> 16209921

Transcription factors and drug resistance.

Kimitoshi Kohno1, Takeshi Uchiumi, Ichiro Niina, Tetsuro Wakasugi, Tomonori Igarashi, Yasutomo Momii, Takeshi Yoshida, Ken-Ichi Matsuo, Naoya Miyamoto, Hiroto Izumi.   

Abstract

Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209921     DOI: 10.1016/j.ejca.2005.08.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Filamin-A as a marker and target for DNA damage based cancer therapy.

Authors:  Jingyin Yue; Huimei Lu; Jingmei Liu; Marianne Berwick; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2011-11-02

Review 2.  Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.

Authors:  Ding-Wu Shen; Lynn M Pouliot; Matthew D Hall; Michael M Gottesman
Journal:  Pharmacol Rev       Date:  2012-06-01       Impact factor: 25.468

3.  Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer.

Authors:  Tingting Li; Honghong Wang; Yimin Sun; Lina Zhao; Yi Gang; Xuegang Guo; Rei Huang; Zhiping Yang; Yanglin Pan; Kaichun Wu; Li Xu; Zhiguo Liu; Daiming Fan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

4.  Trapping of transcription factors with symmetrical DNA using thiol-disulfide exchange chemistry.

Authors:  Markandeswar Panda; Daifeng Jiang; Harry W Jarrett
Journal:  J Chromatogr A       Date:  2008-06-22       Impact factor: 4.759

5.  The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.

Authors:  Xia Li; Xi Zhang; Cong-Cong Wu; Ping-Ping Li; Yi-Mou Fu; Li-Hua Xie; Shuang-Shuang Sun; Ying-Ying Zhou; Bao-Ling Zhu
Journal:  J Mol Histol       Date:  2020-11-03       Impact factor: 2.611

6.  An integrative approach to identifying cancer chemoresistance-associated pathways.

Authors:  Shih-Yi Chao; Jung-Hsien Chiang; A-Mei Huang; Woan-Shan Chang
Journal:  BMC Med Genomics       Date:  2011-03-24       Impact factor: 3.063

Review 7.  Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy.

Authors:  Kimitoshi Kohno; Ke-Yong Wang; Mayu Takahashi; Tomoko Kurita; Yoichiro Yoshida; Masakazu Hirakawa; Yoshikazu Harada; Akihiro Kuma; Hiroto Izumi; Shinji Matsumoto
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

8.  YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.

Authors:  Mohammad Imran Khan; Vaqar Mustafa Adhami; Rahul Kumar Lall; Mario Sechi; Dinesh C Joshi; Omar M Haidar; Deeba Nadeem Syed; Imtiaz Ahmad Siddiqui; Shing-Yan Chiu; Hasan Mukhtar
Journal:  Oncotarget       Date:  2014-05-15

9.  Comparison of selected gene expression profiles in sensitive and resistant cancer cells treated with doxorubicin and Selol.

Authors:  Jadwiga Dudkiewicz-Wilczyńska; Agnieszka Grabowska; Iza Książek; Karolina Sitarz; Piotr Suchocki; Elżbieta Anuszewska
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-03

10.  The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.

Authors:  Y Kawatsu; S Kitada; H Uramoto; L Zhi; T Takeda; T Kimura; S Horie; F Tanaka; Y Sasaguri; H Izumi; K Kohno; S Yamada
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.